CFB
WST icon

Cullen/Frost Bankers’s West Pharmaceutical WST Stock Holding History

Cullen/Frost Bankers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.13M Buy
+22,640
New +$6.92M 0.08% 191
2025
Q1 		– Sell
-8
Closed -$2.62K – 1499
2024
Q4 		$2.62K Buy
8
+3
+60% +$944 ﹤0.01% 1113
2024
Q3 		$1.5K Sell
5
-66
-93% -$20.2K ﹤0.01% 1140
2024
Q2 		$23.4K Buy
+71
New +$25.1K ﹤0.01% 759
2023
Q4 		– Sell
-191
Closed -$71.7K – 1200
2023
Q3 		$71.7K Hold
191
– – ﹤0.01% 662
2023
Q2 		$73.1K Sell
191
-14
-7% -$5K ﹤0.01% 669
2023
Q1 		$71K Hold
205
– – ﹤0.01% 666
2022
Q4 		$48.2K Hold
205
– – ﹤0.01% 709
2022
Q3 		$50K Hold
205
– – ﹤0.01% 700
2022
Q2 		$62K Sell
205
-15
-7% -$4.88K ﹤0.01% 669
2022
Q1 		$90K Hold
220
– – ﹤0.01% 641
2021
Q4 		$103K Hold
220
– – ﹤0.01% 633
2021
Q3 		$93K Hold
220
– – ﹤0.01% 639
2021
Q2 		$79K Sell
220
-10
-4% -$3.3K ﹤0.01% 677
2021
Q1 		$65K Hold
230
– – ﹤0.01% 682
2020
Q4 		$65K Hold
230
– – ﹤0.01% 664
2020
Q3 		$63K Sell
230
-60
-21% -$15.9K ﹤0.01% 629
2020
Q2 		$66K Buy
+290
New +$57K ﹤0.01% 612

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cullen/Frost Bankers's WST Position: Q2 2026 in Review

Cullen/Frost Bankers opened a new position in West Pharmaceutical (WST) in Q2 2026: 22,640 shares worth $8.13M. The stake represents 0.08% of the portfolio and ranks #191 among its holdings. This is a return to the name: Cullen/Frost Bankers previously reported a position in WST as recently as Q4 2024.

Cullen/Frost Bankers first reported a position in WST in Q2 2020 and has held it in 18 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cullen/Frost Bankers held 22,640 shares of West Pharmaceutical worth $8.13M as of Q2 2026.
  • West Pharmaceutical was a new Cullen/Frost Bankers position in Q2 2026.
  • West Pharmaceutical made up 0.08% of Cullen/Frost Bankers's portfolio in Q2 2026, its #191 holding.
  • Cullen/Frost Bankers first reported a position in West Pharmaceutical in Q2 2020 and has held it in 18 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.